Skip to content

ASND ASCENDIS PHARMA A/S

Follow

ORD SHS *A* (common), issuer CIK 1612042

8 managers (8 13F filers) reported a position in ASND shares at 2026-03-31, 7,936,554 shares in all. 8 filers opened a position and 0 filers sold out during the quarter.

Managers
8
13F filers
8
New
8
Added
0
Reduced
0
Sold out
0
Shares held by filers
7,936,554

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
T. Rowe Price Investment Management, In…6,162,042$1.41B0.97%new13F-HRTimeline
PRICE T ROWE ASSOCIATES INC /MD/1,530,345$350M0.04%new13F-HRTimeline
Driehaus Capital Management LLC127,562$29.2M0.21%new13F-HRTimeline
Q Global Advisors, LLCin group Q Global Advisors, LLC100,000$22.9M21.99%new13F-HRTimelineGroup
Evolutionary Tree Capital Management, L…9,070$2.07M3.9%new13F-HRTimeline
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF O…5,784$1.32M<0.01%new13F-HRTimeline
Legato Capital Management LLC1,748$400K0.04%new13F-HRTimeline
SBI Securities Co., Ltd.3$686<0.01%new13F-HRTimeline